| Association of checkpoint inhibitor–induced toxic effects with shared cancer and tissue antigens in non–small cell lung cancer F Berner, D Bomze, S Diem, OH Ali, M Fässler, S Ring, R Niederer, ... JAMA oncology 5 (7), 1043-1047, 2019 | 321 | 2019 |
| Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors OH Ali, F Berner, D Bomze, M Fässler, S Diem, A Cozzio, M Jörger, ... European Journal of Cancer 107, 8-14, 2019 | 147 | 2019 |
| Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer O Hasan Ali, S Diem, E Markert, W Jochum, K Kerl, LE French, ... Oncoimmunology 5 (11), e1231292, 2016 | 110 | 2016 |
| Severe coronavirus disease 2019 (COVID-19) is associated with elevated serum immunoglobulin (Ig) A and antiphospholipid IgA antibodies O Hasan Ali, D Bomze, L Risch, SD Brugger, M Paprotny, M Weber, ... Clinical Infectious Diseases 73 (9), e2869-e2874, 2021 | 106 | 2021 |
| Association between immune-related adverse events during anti–PD-1 therapy and tumor mutational burden D Bomze, OH Ali, A Bate, L Flatz JAMA oncology 5 (11), 1633-1635, 2019 | 105 | 2019 |
| BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors OH Ali, D Bomze, SS Ring, F Berner, M Fässler, S Diem, MT Abdou, ... Journal of the American Academy of Dermatology 82 (4), 854-861, 2020 | 77 | 2020 |
| Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients M Fässler, S Diem, J Mangana, O Hasan Ali, F Berner, D Bomze, S Ring, ... Journal for immunotherapy of cancer 7, 1-12, 2019 | 52 | 2019 |
| A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells E Garreta, P Prado, ML Stanifer, V Monteil, A Marco, A Ullate-Agote, ... Cell Metabolism 34 (6), 857-873. e9, 2022 | 50 | 2022 |
| Anti-PD-1 therapy leads to near-complete remission in a patient with metastatic basal cell carcinoma S Fischer, OH Ali, W Jochum, T Kluckert, L Flatz, M Siano Oncology Research and Treatment 41 (6), 391-394, 2018 | 50 | 2018 |
| Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage … S Diem, O Hasan Ali, CJ Ackermann, D Bomze, VH Koelzer, W Jochum, ... Cancer Immunology, Immunotherapy 67, 39-45, 2018 | 48 | 2018 |
| Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors NG Nunez, F Berner, E Friebel, S Unger, N Wyss, JM Gomez, MT Purde, ... Med 4 (2), 113-129. e7, 2023 | 41 | 2023 |
| Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants V Monteil, B Eaton, E Postnikova, M Murphy, B Braunsfeld, I Crozier, ... EMBO Molecular Medicine 14 (8), e15230, 2022 | 36 | 2022 |
| Ocular adverse events induced by immune checkpoint inhibitors: a comprehensive pharmacovigilance analysis D Bomze, T Meirson, O Hasan Ali, A Goldman, L Flatz, Z Habot-Wilner Ocular immunology and inflammation 30 (1), 191-197, 2022 | 31 | 2022 |
| Immunoglobulin G and subclasses as potential biomarkers in metastatic melanoma patients starting checkpoint inhibitor treatment S Diem, M Fässler, D Bomze, OH Ali, F Berner, R Niederer, D Hillmann, ... Journal of Immunotherapy 42 (3), 89-93, 2019 | 30 | 2019 |
| Survival-inferred fragility index of phase 3 clinical trials evaluating immune checkpoint inhibitors D Bomze, N Asher, OH Ali, L Flatz, D Azoulay, G Markel, T Meirson JAMA network open 3 (10), e2017675-e2017675, 2020 | 26 | 2020 |
| Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs L Loo, MA Waller, CL Moreno, AJ Cole, AO Stella, OT Pop, AK Jochum, ... PLoS biology 21 (2), e3001967, 2023 | 25 | 2023 |
| Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade F Berner, D Bomze, C Lichtensteiger, V Walter, R Niederer, O Hasan Ali, ... Science immunology 7 (75), eabn9644, 2022 | 20 | 2022 |
| Short‐and long‐term effects of two emollients on itching and skin restoration in xerotic eczema D Simon, S Nobbe, M Nägeli, M Barysch, M Kunz, S Borelli, O Hasan‐Ali, ... Dermatologic therapy 31 (6), e12692, 2018 | 18 | 2018 |
| Pulmonary surfactant proteins are inhibited by immunoglobulin A autoantibodies in severe COVID-19 T Sinnberg, C Lichtensteiger, OH Ali, OT Pop, AK Jochum, L Risch, ... American journal of respiratory and critical care medicine 207 (1), 38-49, 2023 | 15 | 2023 |
| Readability assessment of patient education material published by german-speaking associations of urology P Betschart, V Zumstein, O Hasan Ali, HP Schmid, D Abt Urologia internationalis 100 (1), 79-84, 2018 | 11 | 2018 |
